IN2014DN05972A - - Google Patents
Info
- Publication number
- IN2014DN05972A IN2014DN05972A IN5972DEN2014A IN2014DN05972A IN 2014DN05972 A IN2014DN05972 A IN 2014DN05972A IN 5972DEN2014 A IN5972DEN2014 A IN 5972DEN2014A IN 2014DN05972 A IN2014DN05972 A IN 2014DN05972A
- Authority
- IN
- India
- Prior art keywords
- diseases associated
- present
- glucose metabolism
- therapeutic agent
- abnormal glucose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012015351 | 2012-01-27 | ||
| PCT/JP2013/051627 WO2013111870A1 (ja) | 2012-01-27 | 2013-01-25 | 糖尿病の治療薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN05972A true IN2014DN05972A (pt) | 2015-06-26 |
Family
ID=48873581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN5972DEN2014 IN2014DN05972A (pt) | 2012-01-27 | 2013-01-25 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20150005506A1 (pt) |
| EP (1) | EP2808018B1 (pt) |
| JP (1) | JP5924699B2 (pt) |
| KR (1) | KR20140134266A (pt) |
| CN (1) | CN104066430A (pt) |
| AR (1) | AR089812A1 (pt) |
| AU (1) | AU2013212865A1 (pt) |
| BR (1) | BR112014017902A2 (pt) |
| CA (1) | CA2862602A1 (pt) |
| HK (1) | HK1201209A1 (pt) |
| IN (1) | IN2014DN05972A (pt) |
| MX (1) | MX2014008484A (pt) |
| RU (1) | RU2014134845A (pt) |
| TW (1) | TW201334779A (pt) |
| WO (1) | WO2013111870A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104628673A (zh) * | 2015-02-10 | 2015-05-20 | 佛山市赛维斯医药科技有限公司 | 一类含叔丁基脒结构的腈基苯噻唑羧酸酰胺类化合物及用途 |
| CN104628672A (zh) * | 2015-02-10 | 2015-05-20 | 佛山市赛维斯医药科技有限公司 | 一类含苯基脒结构的烷氧苯基噻唑羧酸酰胺类化合物及用途 |
| CN104610188B (zh) * | 2015-02-10 | 2016-07-27 | 佛山市赛维斯医药科技有限公司 | 含苯基脒结构的腈基苯噻唑羧酸酰胺类化合物、其制备及用途 |
| CN104610190B (zh) * | 2015-02-10 | 2016-08-17 | 佛山市赛维斯医药科技有限公司 | 一类含环丙基脒结构的卤代苯基噻唑羧酸酰胺类化合物及用途 |
| CN104628671B (zh) * | 2015-02-10 | 2016-04-13 | 佛山市赛维斯医药科技有限公司 | 含苯基脒结构的硝基苯噻唑羧酸酰胺类化合物及用途 |
| KR102473677B1 (ko) * | 2015-08-17 | 2022-12-02 | 삼성디스플레이 주식회사 | 액정 표시 장치 |
| AR107661A1 (es) | 2016-02-19 | 2018-05-23 | Nat Univ Corp Tottori Univ | Agente terapéutico o profiláctico para la demencia |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992009279A1 (en) * | 1990-11-30 | 1992-06-11 | Teijin Limited | 2-arylthiazole derivative and pharmaceutical composition containing the same |
| HUP9902721A2 (hu) * | 1997-11-25 | 1999-12-28 | The Procter & Gamble Co. | Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület |
| US20050074442A1 (en) * | 2002-03-13 | 2005-04-07 | Natarajan Ranganathan | Compositions and methods for augmenting kidney function |
| JP2008506785A (ja) * | 2004-07-21 | 2008-03-06 | フロリダ大学 リサーチファウンデーション インコーポレイティッド | インスリン抵抗性の治療及び予防のための組成物及び方法 |
| AU2006276933A1 (en) * | 2005-07-21 | 2007-02-15 | University Of Florida Research Foundation, Inc. | Compositions and methods for treatment and prevention of hyperuricemia related health consequences |
| EP1940397A4 (en) | 2005-08-03 | 2010-01-20 | Takeda Pharmaceuticals North A | METHOD FOR TREATING HYPERTONIA |
| JP2009516691A (ja) * | 2005-11-21 | 2009-04-23 | タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド | Ｑｔ間隔延長およびこれに伴う疾病の治療 |
| JP2007210978A (ja) | 2006-02-13 | 2007-08-23 | Hiroshima Univ | 耐糖能障害、ｉｉ型糖尿病、高脂血症、メタボリックシンドローム、内臓脂肪型肥満、脂肪肝または非アルコール性脂肪性肝炎の予防・治療剤 |
| KR20160031040A (ko) | 2006-11-13 | 2016-03-21 | 다케다 파마슈티칼스 유에스에이, 인코포레이티드 | 크산틴 옥시도리덕타아제 억제제를 사용하여 신장 기능을 보존하는 방법 |
| AU2008329673C1 (en) * | 2007-11-27 | 2012-10-25 | Ardea Biosciences, Inc. | Novel compounds and compositions and methods of use |
| WO2009145456A2 (ko) * | 2008-03-31 | 2009-12-03 | 주식회사 씨앤드씨신약연구소 | 헤테로사이클 유도체 |
| CN102014898B (zh) * | 2008-04-30 | 2013-01-23 | 维尔斯达医疗公司 | 用于减少尿酸的四唑化合物 |
| EP2668953A1 (en) * | 2008-05-22 | 2013-12-04 | Bristol-Myers Squibb Company | Pharmaceutical compositions comprising an SGLT2 inhibitor with a supply of carbohydrate and/or an inhibitor of uric acid synthesis |
| US20110257202A1 (en) * | 2008-10-19 | 2011-10-20 | Richard J Johnson | Therapeutic Compositions and Methods for Treating Chronic Kidney Disease Associated with a Metabolic Imbalance |
| US20120219536A1 (en) * | 2009-08-24 | 2012-08-30 | Queensland University Of Technology | Purine-targeted diagnosis and therapy of wounds |
| US9248119B2 (en) * | 2010-06-16 | 2016-02-02 | Takeda Pharmaceuticals U.S.A., Inc. | Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors |
| WO2011162390A1 (ja) * | 2010-06-25 | 2011-12-29 | 帝人ファーマ株式会社 | 徐放性高血圧および腎機能障害治療剤 |
-
2013
- 2013-01-25 CN CN201380006730.6A patent/CN104066430A/zh active Pending
- 2013-01-25 RU RU2014134845A patent/RU2014134845A/ru not_active Application Discontinuation
- 2013-01-25 MX MX2014008484A patent/MX2014008484A/es unknown
- 2013-01-25 BR BR112014017902A patent/BR112014017902A2/pt not_active IP Right Cessation
- 2013-01-25 WO PCT/JP2013/051627 patent/WO2013111870A1/ja active Application Filing
- 2013-01-25 JP JP2013555326A patent/JP5924699B2/ja not_active Expired - Fee Related
- 2013-01-25 AR ARP130100233A patent/AR089812A1/es unknown
- 2013-01-25 TW TW102102886A patent/TW201334779A/zh unknown
- 2013-01-25 IN IN5972DEN2014 patent/IN2014DN05972A/en unknown
- 2013-01-25 CA CA2862602A patent/CA2862602A1/en not_active Abandoned
- 2013-01-25 US US14/372,961 patent/US20150005506A1/en not_active Abandoned
- 2013-01-25 KR KR1020147020342A patent/KR20140134266A/ko not_active Application Discontinuation
- 2013-01-25 EP EP13740913.2A patent/EP2808018B1/en not_active Not-in-force
- 2013-01-25 AU AU2013212865A patent/AU2013212865A1/en not_active Abandoned
-
2015
- 2015-02-25 HK HK15101890.2A patent/HK1201209A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013111870A1 (ja) | 2013-08-01 |
| EP2808018A1 (en) | 2014-12-03 |
| AU2013212865A1 (en) | 2014-08-14 |
| KR20140134266A (ko) | 2014-11-21 |
| EP2808018A4 (en) | 2015-07-15 |
| TW201334779A (zh) | 2013-09-01 |
| JP5924699B2 (ja) | 2016-05-25 |
| AR089812A1 (es) | 2014-09-17 |
| JPWO2013111870A1 (ja) | 2015-05-11 |
| US20150005506A1 (en) | 2015-01-01 |
| CN104066430A (zh) | 2014-09-24 |
| EP2808018B1 (en) | 2018-03-14 |
| HK1201209A1 (en) | 2015-08-28 |
| RU2014134845A (ru) | 2016-03-20 |
| CA2862602A1 (en) | 2013-08-01 |
| BR112014017902A2 (pt) | 2017-08-22 |
| MX2014008484A (es) | 2014-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015MN00404A (pt) | ||
| MX2016006336A (es) | Compuestos pirazolopirimidina. | |
| PH12017501426A1 (en) | Derivatives of betulin | |
| AU2012214029A8 (en) | Rorgammat inhibitors | |
| PH12015502839B1 (en) | Antiviral compounds | |
| MY183312A (en) | Pharmaceutical formulation | |
| MX2015003594A (es) | Agente terapeutico o profilactico para sindrome de lisis tumoral. | |
| GEP20207105B (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors | |
| MX2015017861A (es) | Derivados de benzotiofeno como inhibidores del receptor de estrogeno. | |
| MX2015005286A (es) | Procedimiento para la preparación de derivados del ácido biliar. | |
| MX2015010971A (es) | Derivado novedoso de pirazol. | |
| JO3530B1 (ar) | مركبات بيريدازين 1،4-ثنائية الإرتباط ونظائرها وطرق معالجة نقص smn وحالاته المرضية. | |
| IN2015DN00185A (pt) | ||
| IN2014MN02106A (pt) | ||
| IN2014DN05972A (pt) | ||
| AU2012321815A8 (en) | 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| MY187718A (en) | Pharmaceutical formulations | |
| MX364400B (es) | Compuestos de tetraciclina. | |
| PH12015501752A1 (en) | Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors | |
| WO2011123536A8 (en) | Polycyclic tetracycline compounds | |
| MX2021010046A (es) | Nueva composicion terapeutica que contiene ingrediente activo de apomorfinas. | |
| NZ711343A (en) | Sodium salt of (2s, 5r)-6-benzyloxy-7-oxo-1,6-diaza-bicyclo [3.2.1 ] octane-2-carboxylic acid and its preparation | |
| IN2014CN04449A (pt) | ||
| MX362919B (es) | Moduladores del receptor acoplado a proteína-g 120 (gpr120) de ácido biciclo-[2.2.1]. | |
| MY173491A (en) | Therapeutic or prophylactic agent for biliary tract diseases |